Asia-Pacific Cannabis Testing Market was worth USD 180 million in 2016 and estimated to be growing at a CAGR of 11.6%, to reach USD 312 million by 2021.
Cannabis Testing methods define various methods for detecting cannabis usage in the fields of sport, law and medicine. Some of the tests used for detection are blood testing, urine testing, hair testing and saliva testing. Discerning the usage of cannabis usually requires a lot of time, no matter which method is used. Tests like Duquenois-Levine can detect the usage of cannabis in a short amount of time, but the test is unreliable since it gives false positive for other substances as well.
Cannabis use by urine testing can be detected 2-5 days after usage in infrequent users and about 15 days in heavy users. Blood testing is not used often as it is invasive, it can detect usage within 12-24 hours of use in infrequent users and in heavy users it can detect in 7 days window after usage. By hair testing usage can be discerned even after 90 days of usage and main advantage of this method being detection of concentrations as low as 1 pg/mg of sample. By saliva testing, abuse can be discerned in a window of 3 days, but it can detect compounds having concentration even in the range of 0.5 ng/mL.
The key driving factors of Asia-Pacific Cannabis testing market are rising accidents under cannabis intoxication, cannabis legalisation in some regions for medical and recreational purposes, growing usage of LIMS, increasing number of seminars and conferences to increase awareness about these tests and growing number of cannabis testing laboratories among others. However, this market is constrained by limited number of skilled professionals, high price of instruments for testing cannabis usage, and presence of alternative technologies.
The Asia-Pacific Cannabis Testing market is segmented on the basis of product & software into analytical instruments, consumables and software. Based on testing procedures, the market is divided into terpene profiling, potency testing, residual solvent screening, pesticide screening, genetic testing, heavy metal testing and microbial analysis. Potency testing has the highest market share in this segment. On the basis of end-users, the market is divided into cannabis cultivators, laboratories, drug manufacturers & dispensaries, and research institutes. Laboratories accounted for the largest market share in this segment owing to rising demand for cannabis testing software in labs.
The Asia-Pacific market for Cannabis Testing is geographically segmented into India, China, Thailand, Australia and others. The developing economies in Asia-Pacific are the fastest growing regions in the world. Factors like rising number of road accidents under the influence of cannabis and legalisation for medical and recreational purposes in some regions is expected to surge the growth in this region.
Some of the major players in the market include Agilent Technologies, Inc., Shimadzu Corporation, Waters Corporation, PerkinElmer, Inc., AB SCIEX LLC, Millipore Sigma, Restek Corporation, LabLynx, Inc. (U.S.), Steep Hill Labs, Inc., PharmLabs, LLC, SC Laboratories, Inc., Digipath Labs, Inc., CannaSafe Analytics, and Accelerated Technology Laboratories, Inc.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
credit:420intel.com
